RAVGEN
Ravgen specializing in non-invasive prenatal genetic testing and paternity testing, Ravgen is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA present in maternal blood. Diagnose single gene disorders, such as cystic fibrosis, sickle cell anemia and Downs syndrome, establish paternity and more early on in pregnancy.
RAVGEN
Industry:
Biotechnology Genetics Health Care
Founded:
2000-01-01
Address:
Columbia, Maryland, United States
Country:
United States
Website Url:
http://www.ravgen.com
Total Employee:
1+
Status:
Active
Contact:
410-715-2111
Email Addresses:
[email protected]
Total Funding:
3.57 M USD
Technology used in webpage:
Google Maps Apple Whitelist
Current Employees Featured
Founder
Official Site Inspections
http://www.ravgen.com
- Host name: box5917.bluehost.com
- IP address: 162.241.30.56
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Ravgen"
Home - Ravgen
Ravgen’s technology allows for non-invasive prenatal genetic testing for single gene disorders and chromosomal abnormalities, such as CF, SMA, and sickle cell anemia. Feel free to …See details»
Who We Are - Ravgen
Ravgen’s mission is to provide state of the art genetic testing that will enrich the lives of its patients. Through noninvasive prenatal diagnostic tests, Ravgen gives patients the knowledge they need to prepare for their pregnancies and treat …See details»
Ravgen - Wikipedia
Ravgen Inc. is a privately owned biotech company founded in 2000 by Chairman and C.E.O. Dr. Ravinder Dhallan. Ravgen Inc. performs research in the prenatal diagnostic field and has developed non-invasive prenatal diagnosis testing for Down Syndrome. See details»
Ravgen - Crunchbase Company Profile & Funding
Ravgen specializing in non-invasive prenatal genetic testing and paternity testing, Ravgen is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA present in …See details»
Ravgen Company Profile 2024: Valuation, Funding
Developer of prenatal diagnostic tests designed to offer genetic testing that will enrich the lives of patients. The company develops non-invasive prenatal genetic tests based on fetal deoxyribonucleic acid present in maternal blood, enabling …See details»
Ravinder Dhallan - Wikipedia
In order to develop and exploit his procedure, Dhallan founded and incorporated the biotech startup firm RavGen. Meanwhile, he left oncology to do a residency in emergency medicine at …See details»
Our Research - Ravgen
Currently, the focus for Ravgen’s core technology is on testing for single gene disorders, such as cystic fibrosis, sickle cell anemia, and the Jewish panel, as well as prenatal paternity testing.See details»
Ravgen, Inc - VentureRadar
Website: http://www.ravgen.com/ Ravgen Inc., is a privately owned biotech company founded by Chairman and C.E.O. Dr. Ravinder Dhallan.See details»
RAVGEN, INC. Company Profile | Columbia, MD - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for RAVGEN, INC. of Columbia, MD. Get the latest business insights from Dun & Bradstreet.See details»
Ravgen - Products, Competitors, Financials, Employees, …
Ravgen is a biotechnology company with a high-level focus on prenatal diagnostic testing. The company offers non-invasive prenatal diagnostic tests based on fetal DNA present in maternal …See details»
Ravgen Company Profile - Office Locations, Competitors, Revenue …
Ravgen is a biotechnology company focused on prenatal diagnostic testing. It is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA present in maternal blood.See details»
RAVGEN, INC. | Reuters
Apr 17, 2023 · Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology. The most comprehensive solution to manage all …See details»
Prenatal Single Gene Tests - Ravgen
Our goal is to develop a fetal DNA based sequencing method to allow for safe, noninvasive, and accurate prenatal diagnosis of genetic disorders early in pregnancy. Ravgen published its …See details»
His tiny prenatal testing company has big plans after exacting …
Aug 17, 2023 · Ravinder Dhallan’s name is on key patents in noninvasive prenatal testing, a field that has reshaped screening for expectant mothers. But he was a minor figure in the $3.8 …See details»
Natera owes Ravgen $57 million in genetic-testing case, Texas jury …
Jan 16, 2024 · Genetic-testing company Natera must pay Maryland biotech company Ravgen $57 million in damages for infringing one of Ravgen's patents, a jury in Austin, Texas, said on …See details»
Ravgen - Overview, News & Similar companies | ZoomInfo.com
Who is Ravgen. Specializing in non-invasive prenatal genetic testing and paternity testing, Ravgen is focused on developing non-invasive prenatal diagnostic tests based on fetal DNA …See details»
Quest faces next Ravgen DNA testing patent trial after $272 mln …
Sep 26, 2022 · Biotech company Ravgen Inc obtained a $272 million patent verdict against Laboratory Corporation of America on Friday, winning over jurors in Waco, Texas in the first …See details»
Trial-focused: Lead counsel on how a strong story helped Ravgen …
Jan 25, 2024 · 24 December 2020 Biotechnology company Ravgen has accused Myriad Genetics and Myriad Women’s Health of infringing two patents covering non-invasive DNA testing …See details»
News and Publications - Ravgen
Feb 3, 2004 · First-Trimester Blood Test May Tell New, noninvasive method safer than current ones, developer says. By Maureen Salamon HealthDay Reporter WEDNESDAY, May 2 …See details»
‘We took Ravgen head-on’: How we won zero-damages and …
Nov 19, 2024 · In an interview with Life Sciences Intellectual Property Review, Partner Michael Summersgill discusses how his team achieved more favorable outcomes than others in a …See details»